Press

Datwyler in the media

13 results For “FecT” Clear filter

2024

MDPI 2024-01-10 SoftPulse™
Multi-Channel Soft Dry Electrodes for Electrocardiography Acquisition in the Ear Region
Datwyler and imec The Netherlands have published a study investigating the effectiveness of (smartlink: softpulse) soft dry electrodes for in-ear electrocardiography. This study underscores Datwyler’s commitment to advancing wearable health technologies and emphasizes the potential of SoftPulse™ electrodes in redefining in-ear biosignal monitoring.

2023

European Pharmaceutical Manufacturer 2023-03-15
“PERFECTing” the pharma packaging selection process
Gabrielle Gehron, Scientific Support Manager at Datwyler, explains how to successfully analyze your pharma packaging needs and navigate through the packaging selection process.
European Pharmaceutical Manufacturer | Mar 15, 2023

2022

Express Pharma, Volume 18 Issue 01
«PERFECTing» the package selection process
Gabrielle Gehron, Scientific Support Manager, Datwyler, explains how one can successfully analyse packaging needs and navigate through the packaging selection process
Express Pharma, Volume 18 Issue 01 |

2021

Konstruktionspraxis, Issue 2021/10
How environmentally friendly are hybrid vehicles?
How environmentally friendly a hybrid vehicle is, depends on a great many variables, not least the way in which the boundaries of assessment are drawn. What is often overlooked is the fact that the effectiveness of plug-in hybrid vehicles in terms of their environmental impact depends very much on the driving and charging discipline of their users, especially in the case of large SUVs or luxury vehicles, which are common with this type of powertrain.
Konstruktionspraxis, Special Edition 10/2021 |
Pharmaceutical Technology 2021-04-28 a
Quality is king: The case to put quality first in pharmaceutical packaging
Datwyler’s Technical Key Account Manager, Rahul Thakar, discusses how Datwyler’s highest quality standard, FirstLine®, helps pharmaceutical companies minimize defects.
Pharmaceutical Technology | Apr 28, 2021
Pharmaceutical Technology 2021-04-28 c
Smart goals and continuous improvement for a resilient sustainability strategy
Forecasts on the effects of climate change have prompted all industries, including the pharmaceutical sector, to implement more environmentally responsible practices.
Pharmaceutical Technology | Apr 28, 2021
Pharma Technology Focus, Issue 103
Drug Defense: Designing Against Defects.
In times of crisis—like the current COVID-19 pandemic—there is no time or resource to waste on the issues that stem from defective or problematic drug packaging. Datwyler’s Key Account Manager, Rahul Thakar, explains how quality-by-design thinking enables drug efficacy and minimized opportunities for contamination.
Pharma Technology Focus, Issue 103 | Feb 1, 2021

2020

Manufacturing Chemist 2020-12-09
Drug defence: designing against defects
«Quality by Design» thinking enables drug efficacy and minimises opportunities for contamination.
Manufacturing Chemist | Dec 9, 2020
Packaging News 2020-12-03
Designing against defects
Datwyler’s Technical Key Account Manager, Rahul Thakar, discusses how ‘Quality-by-design’ enables drug efficacy & minimises contamination.
Packaging News | Dec 3, 2020
OFweek 2020-10-21
Drug Protection: Eliminate Defects
In OFWeek, Datwyler discusses how to set goals for zero defects in pharmaceutical packaging manufacturing and why this is a critical process consideration, especially during a pandemic.
OFweek | Oct 21, 2020
Dicht, Volume 2020 Issue 3
More than halving development times is not uncommon
Simulation opens up great potential for rationalisation in component development. The automotive industry is a key driver for many developments in the sealing and polymer sector. This already has an effect during prototyping. DICHT! discussed why this is the case with Rudolf Randler, Head of Simulation, Andreas Minatti, Head of Business Development, and Konrad Dubler, Team Leader Engineering Mobility of Datwyler Switzerland Ltd.
Dicht, Volume 2020 Issue 3 |
PMPS, Issue 2020/08
Achieving Zero Defects in a Pandemic
When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
BioSpectrum Asia 2020-07-07
«Aiming for Perfection in a Pandemic», an opinion by Datwyler
«When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
BioSpectrum Asia | Jul 7, 2020